Oppenheimer & Co. Inc. Decreases Stake in Intuitive Surgical, Inc. $ISRG

Oppenheimer & Co. Inc. lowered its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,630 shares of the medical equipment provider’s stock after selling 1,877 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Intuitive Surgical were worth $11,118,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently modified their holdings of the company. Newbridge Financial Services Group Inc. raised its stake in shares of Intuitive Surgical by 300.0% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 33 shares during the last quarter. Holos Integrated Wealth LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter worth $25,000. Olistico Wealth LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter worth $28,000. Laurel Wealth Advisors LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter worth $31,000. Finally, Turning Point Benefit Group Inc. raised its stake in shares of Intuitive Surgical by 833.3% in the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after purchasing an additional 50 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG opened at $457.78 on Friday. Intuitive Surgical, Inc. has a one year low of $427.84 and a one year high of $603.88. The firm has a market capitalization of $162.13 billion, a P/E ratio of 55.49, a PEG ratio of 3.67 and a beta of 1.51. The business has a fifty day moving average of $474.86 and a 200 day moving average of $515.98.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. The business had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The business’s quarterly revenue was up 23.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.81 earnings per share. Analysts expect that Intuitive Surgical, Inc. will post 8.53 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages recently commented on ISRG. Robert W. Baird lifted their price objective on Intuitive Surgical from $575.00 to $610.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. JPMorgan Chase & Co. cut their price objective on Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Citigroup raised Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price objective for the company in a report on Wednesday, March 11th. Argus cut their price objective on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a report on Wednesday, February 4th. Finally, Mizuho set a $525.00 price objective on Intuitive Surgical and gave the stock a “neutral” rating in a report on Monday, April 13th. Eighteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $581.91.

Insiders Place Their Bets

In other Intuitive Surgical news, SVP Mark Brosius sold 645 shares of the company’s stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $485.01, for a total value of $312,831.45. Following the completion of the sale, the senior vice president owned 1,613 shares in the company, valued at $782,321.13. This represents a 28.57% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Myriam Curet sold 105 shares of the company’s stock in a transaction dated Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total value of $51,864.75. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 5,906 shares of company stock valued at $2,907,726. 0.60% of the stock is currently owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.